{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:47:04Z","timestamp":1764020824494,"version":"3.30.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.yebeh.2024.110162","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:46:41Z","timestamp":1732855601000},"page":"110162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Shortage of antiseizure medication in Germany: How big is the problem?"],"prefix":"10.1016","volume":"162","author":[{"given":"Josephine","family":"Steidl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajo M.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.110162_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.693426","article-title":"Drug shortage: causes, impact, and mitigation strategies","volume":"12","author":"Shukar","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.yebeh.2024.110162_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215837","article-title":"The impacts of medication shortages on patient outcomes: a scoping review","volume":"14","author":"Phuong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2024.110162_b0015","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2146\/ajhp110210","article-title":"Impact of drug shortages on U.S. health systems","volume":"68","author":"Kaakeh","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.yebeh.2024.110162_b0020","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages","volume":"75","author":"Fox","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.yebeh.2024.110162_b0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(12)61381-6","article-title":"Epilepsy in poor regions of the world","volume":"380","author":"Newton","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.110162_b0030","article-title":"Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting","volume":"141","author":"Welton","year":"2023","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0035","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.25353","article-title":"Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: a nationwide study of prescription data in Germany","volume":"84","author":"Lang","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2024.110162_b0040","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.2174\/1381612823666170809103202","article-title":"Antiepileptic treatments in developing countries","volume":"23","author":"Jost","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2024.110162_b0045","article-title":"Seizure control and complications in patients switching from clobazam to clonazepam due to drug shortage","volume":"153","author":"F\u0131rat","year":"2024","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/epi.13974","article-title":"A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy","volume":"59","author":"Lukmanji","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110162_b0055","article-title":"Supply problems of antiseizure medication are common among epilepsy patients in Germany","volume":"138","author":"Mann","year":"2023","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0060","doi-asserted-by":"crossref","first-page":"22287","DOI":"10.1038\/s41598-023-49606-z","article-title":"Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach","volume":"13","author":"Wong","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2024.110162_b0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.yebeh.2008.12.006","article-title":"Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy","volume":"14","author":"Manjunath","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110162_b0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.healthpol.2010.02.010","article-title":"Pharmaceutical supply chain in China: current issues and implications for health system reform","volume":"97","author":"Yu","year":"2010","journal-title":"Health Policy"},{"key":"10.1016\/j.yebeh.2024.110162_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/14604582211011228","article-title":"Blockchain for drug traceability: architectures and open challenges","volume":"27","author":"Uddin","year":"2021","journal-title":"Health Informatics J"},{"key":"10.1016\/j.yebeh.2024.110162_b0080","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (BfArM). Arzneimittel: Lieferengp\u00e4sse. 2024. https:\/\/www.bfarm.de\/DE\/Arzneimittel\/_FAQ\/Arzneimittelinformationen\/Lieferengpaesse\/faq-liste.html;jsessionid=0289C0692FE06C9BB46F25ABDA146200.intranet261?nn=471282). Accessed 11 Jul 2024."},{"key":"10.1016\/j.yebeh.2024.110162_b0085","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jval.2018.04.1826","article-title":"Predictors of drug shortages and association with generic drug prices: a retrospective cohort study","volume":"21","author":"Dave","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.yebeh.2024.110162_b0090","article-title":"Current situation, determinants, and solutions to drug shortages in shaanxi province, china: a qualitative study","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2024.110162_b0095","article-title":"The impact of the COVID-19 pandemic on people with epilepsy and epilepsy specialists","volume":"147","author":"Zhang","year":"2023","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0100","article-title":"The impact of the coronavirus disease (COVID-19) pandemic on outpatient epilepsy care: an analysis of physician practices in Germany","volume":"117","author":"Mueller","year":"2021","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/2013.jamainternmed.997","article-title":"Variations in pill appearance of antiepileptic drugs and the risk of nonadherence","volume":"173","author":"Kesselheim","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.yebeh.2024.110162_b0110","first-page":"316","article-title":"Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians","volume":"13","author":"Hovinga","year":"2008","journal-title":"EpilepsyBehav"},{"key":"10.1016\/j.yebeh.2024.110162_b0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/s12913-021-06812-7","article-title":"What impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionals","volume":"21","author":"Atif","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.yebeh.2024.110162_b0120","first-page":"783","article-title":"Effects on patient care caused by drug shortages: a survey","volume":"19","author":"McLaughlin","year":"2013","journal-title":"J Manag Care Pharm"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024005444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T04:06:44Z","timestamp":1733717204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024005444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S1525505024005444"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110162","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shortage of antiseizure medication in Germany: How big is the problem?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110162"}}